Kalle Jokelainen

2.2k total citations
30 papers, 1.4k citations indexed

About

Kalle Jokelainen is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Kalle Jokelainen has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Hepatology. Recurrent topics in Kalle Jokelainen's work include Gallbladder and Bile Duct Disorders (12 papers), Liver Diseases and Immunity (11 papers) and Alcohol Consumption and Health Effects (8 papers). Kalle Jokelainen is often cited by papers focused on Gallbladder and Bile Duct Disorders (12 papers), Liver Diseases and Immunity (11 papers) and Alcohol Consumption and Health Effects (8 papers). Kalle Jokelainen collaborates with scholars based in Finland, United States and Hong Kong. Kalle Jokelainen's co-authors include Amin A. Nanji, Amir Rahemtulla, Andrew J. Dannenberg, George L. Tipoe, Peter Thomas, Jaakko‐Juhani Himberg, Timo Sahi, Matti J. Tikkanen, Reijo Laaksonen and Grace L. Su and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Kalle Jokelainen

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kalle Jokelainen Finland	14	458	417	400	343	215	30	1.4k
Yohei Shirakami Japan	29	912 2.0×	648 1.6×	428 1.1×	176 0.5×	163 0.8×	91	2.3k
Hong Feng China	20	549 1.2×	239 0.6×	740 1.9×	236 0.7×	403 1.9×	49	1.8k
Charles S. Lieber United States	18	475 1.0×	838 2.0×	625 1.6×	175 0.5×	208 1.0×	22	1.7k
Shamsuddin Khwaja United States	16	285 0.6×	284 0.7×	255 0.6×	107 0.3×	119 0.6×	25	1.1k
Tadayoshi Okumura Japan	31	965 2.1×	136 0.3×	302 0.8×	390 1.1×	381 1.8×	94	2.3k
Amir Rahemtulla United States	16	383 0.8×	611 1.5×	699 1.7×	147 0.4×	206 1.0×	21	1.6k
Anna Planagumà Spain	16	275 0.6×	90 0.2×	352 0.9×	211 0.6×	224 1.0×	23	1.3k
Carlo Clerici Italy	17	570 1.2×	802 1.9×	640 1.6×	599 1.7×	519 2.4×	41	2.5k
M. F. Sorrell United States	20	411 0.9×	538 1.3×	491 1.2×	195 0.6×	214 1.0×	34	1.4k
Petr Protiva United States	22	384 0.8×	228 0.5×	149 0.4×	208 0.6×	189 0.9×	36	1.6k

Countries citing papers authored by Kalle Jokelainen

Since Specialization

Citations

This map shows the geographic impact of Kalle Jokelainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalle Jokelainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalle Jokelainen more than expected).

Fields of papers citing papers by Kalle Jokelainen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kalle Jokelainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalle Jokelainen. The network helps show where Kalle Jokelainen may publish in the future.

Co-authorship network of co-authors of Kalle Jokelainen

This figure shows the co-authorship network connecting the top 25 collaborators of Kalle Jokelainen. A scholar is included among the top collaborators of Kalle Jokelainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kalle Jokelainen. Kalle Jokelainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Färkkilâ, Martti, Hannu Kautiainen, Kalle Jokelainen, et al.. (2024). The new definition of dominant stricture in primary sclerosing cholangitis: Prevalence and clinical significance. Liver International. 44(9). 2351–2358.

Tenca, Andrea, Kaija‐Leena Kolho, Dario Consonni, Kalle Jokelainen, & Martti Färkkilâ. (2024). Dominant stricture in paediatric‐onset primary sclerosing cholangitis is associated with impaired prognosis in a long‐term follow‐up. United European Gastroenterology Journal. 12(6). 717–725. 1 indexed citations

Kaasalainen, Touko, A. Pekkarinen, Leena Kylänpää, et al.. (2023). Occupational radiation dose from gastrointestinal endoscopy procedures with special emphasis on eye lens doses in endoscopic retrograde cholangiopancreatography. SHILAP Revista de lepidopterología. 11(3). E237–E246. 3 indexed citations

Färkkilâ, Martti, Hannu Kautiainen, Andrea Tenca, Kalle Jokelainen, & Johanna Arola. (2022). PNPLA3 allele frequency has no impact on biliary bile acid composition or disease course in patients with primary sclerosing cholangitis. PLoS ONE. 17(12). e0277084–e0277084. 1 indexed citations

Koistinen, Hannu, Riitta Koistinen, Kristina Hotakainen, et al.. (2022). Immunoassay for trypsinogen-4. Analytical Biochemistry. 648. 114681–114681.

Aronen, Pasi, Martti Färkkilâ, Leena Kylänpää, et al.. (2021). Use of thiopurines is not a risk factor for post-ERC pancreatitis in patients with primary sclerosing cholangitis. Digestive and Liver Disease. 53(8). 1020–1027. 2 indexed citations

Tenca, Andrea, Marianne Udd, Outi Lindström, et al.. (2020). Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography. United European Gastroenterology Journal. 8(4). 462–471. 8 indexed citations

Pereira, Pedro A. B., Velma T. E. Aho, Johanna Arola, et al.. (2017). Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia. PLoS ONE. 12(8). e0182924–e0182924. 72 indexed citations

Nanji, Amin A., Andrew J. Dannenberg, Kalle Jokelainen, & Nathan M. Bass. (2004). Alcoholic Liver Injury in the Rat Is Associated with Reduced Expression of Peroxisome Proliferator-α (PPARα)-Regulated Genes and Is Ameliorated by PPARα Activation. Journal of Pharmacology and Experimental Therapeutics. 310(1). 417–424. 86 indexed citations

10.

Jokelainen, Kalle, et al.. (2001). Dietary Saturated Fatty Acids Reverse Inflammatory and Fibrotic Changes in Rat Liver Despite Continued Ethanol Administration. Journal of Pharmacology and Experimental Therapeutics. 299(2). 638–644. 84 indexed citations

11.

Jokelainen, Kalle, Lester A. Reinke, & Amin A. Nanji. (2001). NF-κB ACTIVATION IS ASSOCIATED WITH FREE RADICAL GENERATION AND ENDOTOXEMIA AND PRECEDES PATHOLOGICAL LIVER INJURY IN EXPERIMENTAL ALCOHOLIC LIVER DISEASE. Cytokine. 16(1). 36–39. 47 indexed citations

12.

Jokelainen, Kalle, Seppo Parkkila, Mikko Salaspuro, & Onni Niemelä. (2000). Covalent adducts of proteins with acetaldehyde in the liver as a result of acetaldehyde administration in drinking water. Journal of Hepatology. 33(6). 926–932. 12 indexed citations

13.

Nanji, Amin A., Kalle Jokelainen, Amir Rahemtulla, et al.. (1999). Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology. 30(4). 934–943. 199 indexed citations

14.

Jokelainen, Kalle, Peter Thomas, Kai O. Lindros, & Amin A. Nanji. (1998). Acetaldehyde Inhibits NF-κB Activation through IκBα Preservation in Rat Kupffer Cells. Biochemical and Biophysical Research Communications. 253(3). 834–836. 27 indexed citations

15.

Laaksonen, Reijo, Kalle Jokelainen, Juha Laakso, et al.. (1996). The effect of Simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle. The American Journal of Cardiology. 77(10). 851–854. 140 indexed citations

16.

Matysiak‐Budnik, Tamara, et al.. (1996). HEPATOTOXICITY AND ABSORPTION OF EXTRAHEPATIC ACETALDEHYDE IN RATS. The Journal of Pathology. 178(4). 469–474. 35 indexed citations

17.

Karila, Tuomo, et al.. (1996). The effects of anabolic androgenic steroids on serum ubiquinone and dolichol levels among steroid abusers. Metabolism. 45(7). 844–847. 2 indexed citations

18.

Laaksonen, Reijo, Kalle Jokelainen, Timo Sahi, Matti J. Tikkanen, & Jaakko‐Juhani Himberg. (1995). Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans*. Clinical Pharmacology & Therapeutics. 57(1). 62–66. 135 indexed citations

19.

Jokelainen, Kalle, Katja S. Salmela, Risto Roine, et al.. (1992). Blood dolichol in lysosomal diseases. Biochemistry and Cell Biology. 70(6). 481–485. 13 indexed citations

20.

Kärkkäinen, Päivi, Kalle Jokelainen, Risto O. Roine, Antti Suokas, & Mikko Salaspuro. (1990). The effects of moderate drinking and abstinence on serum and urinary β-hexosaminidase levels. Drug and Alcohol Dependence. 25(1). 35–38. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact